Goldman Sachs: No Longer Expects Fed to Cut Rates This Year Due to Strong Labor Market
BlockBeats News, June 8th, a Goldman Sachs economist stated that due to a stronger-than-expected labor market, the Fed is no longer expected to cut interest rates this year. The bank has pushed back its expected timing for the Fed's last two rate cuts from December 2026 and March 2027 to June 2027 and December 2027.
However, Goldman's Chief U.S. Economist, Mericle, pointed out that due to inflation "seemingly unlikely to become self-sustaining," the possibility of the Fed raising rates remains slim. The strong job growth in May, exceeding all expectations, has shown the resilience of the labor market and intensified market bets on the central bank's rate hikes.
Goldman continues to believe that the likelihood of a rate hike is low but has raised the probability of a small rate hike from 10% to 20%. The bank's baseline forecast still expects two 25-basis-point rate cuts next year, but the probability has decreased from 40% to 30%. Goldman has also lowered its forecast for this year's U.S. unemployment rate from the previous 4.6% to 4.4%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China
According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Abu Dhabi National Oil Company invites bids for crude oil cargo shipments
Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.
The Central Bank of Turkey conducts a 6-ton gold-for-lira weekly sell swap auction.
The Central Bank of Turkey conducted a one-week gold-for-lira sell swap auction using traditional methods, with a scale of 6 tons.
European Court of Auditors: EU debt continues to rise and may reach 1 trillion euros by 2027
On October 8 local time, the European Court of Auditors (ECA) released its 2025 annual report, expressing concerns over the continuous growth of EU debt. According to the report, by the end of 2025, the EU's debt had reached approximately 740 billion euros. The report also warns that this figure may further rise to 1 trillion euros by 2027. The ECA pointed out that the increase in EU debt is mainly related to aid for Ukraine, rising interest rates, defense spending, and the EU recovery fund. (CCTV)
Crypto prices
More
